THE Department of Health has
announced that there is a national
shortage of Saizen solution for
injection (somatropin).
Saizen is subsidised through the
PBS Growth Hormone Program.
The shortage arises from a drug
recall from the supplier of all short
dated Saizen, and the Department
has ceased supplying this PBS item
until sufficient supply is guaranteed.
Patients using Saizen are advised
to ensure that their supply does
not expire before the end of their
treatment period, and if it does, to
contact their pharmacy and doctor
as soon as possible to arrange
replacement medicine.
See www.health.gov.au/hgh.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Aug 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Aug 12
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.